𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cell loss and the concept of potential doubling time

✍ Scribed by A. Bertuzzi; A. Gandolfi; C. Sinisgalli; G. Starace; P. Ubezio


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
70 KB
Volume
29
Category
Article
ISSN
0196-4763

No coin nor oath required. For personal study only.

✦ Synopsis


The in vivo infusion of Bromodeoxyuridine (BrdUrd), followed by delayed biopsy and bivariate DNA-BrdUrd flow cytometry, allows the potential doubling time (T pot ) of human tumors to be estimated. According to Steel, the mathematical definition of T pot is T pot ‫؍‬ ln 2/K p , where K p is the rate constant of cell production. All the operative formulas which allow the estimation of T pot from flow cytometric data derive from this definition. Most authors, however, identify the potential doubling time as the doubling time that the same cell population would exhibit if cell loss were removed. We denote here as T d noloss this quantity. Although these two definitions are equivalent in the case of uniform random cell loss, we show, in the framework of Steel's theory of growing cell populations, that T pot and T d noloss become distinct kinetic quantities when cell loss is not uniform, i.e., when loss differently affects the quiescent and the proliferative compartment. We discuss the validity of the two formulas currently used for the calculation of T pot , one based on LI and the other on the -function, in conditions of non-uniform cell loss. Moreover, we propose two formulas for the estimation of the cycle time T c , which require, in addition to T S and LI, that a measure of the growth fraction be available. Cytometry 29:34-40, 1997.


πŸ“œ SIMILAR VOLUMES


Comparison between endoscopic and surgic
✍ Pierre Michel; Jacques Hemet; Marianne Paresy; Jean FranΓ§ois Menard; Annie Laque πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 52 KB πŸ‘ 2 views

In colorectal cancer, tumoral kinetic parameters could influence the therapeutic strategy. The aim of this study was to test the validity of a preoperative assessment of tumoral kinetics on biopsies obtained from endoscopic sampling. After infusion of 250 mg of bromodeoxyuridine (BrdUrd), tumor samp